Contact Information
Company Information
Company
Cellectar Biosciences, Inc.
Technologies
Route 53
Outlook
Microsoft Office 365
Amazon AWS
Apache
Google Font API
Mobile Friendly
Google Tag Manager
Render
AI
Remote
Keywords
pdc cancer therapeutics & diagnostics
targeted delivery of oncologic payloads
earlystage chemotherapeutic drug conjugates
hematologic malignancies
biotechnology
life sciences
biotechnology: pharmaceutical preparations
health care
cellectar biosciences
cancer therapy
phospholipid drug conjugate
pdc platform
iopofosine i 131
targeted delivery
cancer treatment
clinical studies
drug development
oncology research
b-cell malignancies
waldenstrom macroglobulinemia
multiple myeloma
pediatric cancers
chemotherapeutic programs
targeted radiotherapy
disease management
pharmacological innovation
preclinical studies
collaborative research
medical partnerships
tumor targeting
safety profiles
efficacy improvement
streamlined drug discovery
biopharmaceuticals
patient outcomes
metabolic targeting
strategic collaborations
accelerated approval
regulatory pathways
drug candidates
oncology pipelines
clinical trials
pharmaceutical therapies
patient care
cancer stem cells
preemptive interventions
research partnerships
biotech innovations
chemical engineering
molecular targeting
therapeutic advancements
radioisotope therapy
phospholipid technology
clinical efficacy
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans